Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2018

Sep 13, 2018

30786_dirs_2018-09-13_23a7c33d-b994-411d-9484-37ee0c6e345c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2018-09-11

Reporting Person: Crowley Michael (EVP, GBL Commercial Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-09-11 Bio-Rad A Common Stock M 976 Acquired 4156 Direct
2018-09-11 Bio-Rad A Common Stock F 339 $308.37 Disposed 3817 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-09-11 Restricted Stock Units $0 M 376 Disposed Bio-Rad A Common Stock (376) Direct
2018-09-11 Restricted Stock Units $0 M 600 Disposed Bio-Rad A Common Stock (600) Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: The restricted stock units vest in five equal annual installments beginning September 11, 2014.

F4: The restricted stock units vest in five equal annual installments beginning September 11, 2016.